Physician profile
Cole R Linville
NPI 1851735377
$31,905.64
in general payments reported to CMS, 2019-2025
37 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Neuromuscular Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $128).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.80 · 2020: $64.43 · 2021: $1,485 · 2022: $4,475 · 2023: $3,520 · 2024: $10K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $9,001 · Travel and Lodging: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,512.50 |
| Food and Beverage | $9,000.90 |
| Travel and Lodging | $1,352.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $28,148.83 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Collegium Pharmaceutical, INC. | $866.69 | 2021-2025 | Xtampza, Belbuca |
| Tersera Therapeutics LLC | $311.71 | 2021-2025 | Prialt |
| Medtronic, INC. | $263.81 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Vertos Medical, INC. | $233.80 | 2019-2024 | Mild Device Kit |
| Azurity Pharmaceuticals, INC. | $209.00 | 2023-2025 | Horizant, Horizant |
| Biodelivery Sciences International, INC. | $178.04 | 2021 | |
| Ethicon INC. | $156.47 | 2024 | Monarch Platform |
| Spr Therapeutics, INC | $137.80 | 2022-2025 | Sprint Pns System |
| Nevro Corp. | $124.00 | 2021-2024 | Senza |
| Nalu Medical, INC. | $116.93 | 2021-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $113.04 | 2025 | Senza |
| Redhill Biopharma INC. | $112.11 | 2021 | |
| Saluda Medical Americas, INC. | $103.55 | 2025 | Evoke |
| Protega Pharmaceutials INC | $92.60 | 2025 | Roxybond |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $76.12 | 2021-2024 | |
| Almatica Pharma LLC | $75.60 | 2021-2022 | |
| Painteq LLC | $58.28 | 2023-2024 | Painteq |
| Biohaven Pharmaceuticals, INC. | $52.48 | 2021 | |
| Curonix LLC | $44.83 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceutical Holding Company Ltd. | $40.64 | 2022 | |
| Pfizer INC. | $35.47 | 2023 | |
| Ani Pharmaceuticals, INC. | $34.45 | 2025 | Purified Cortrophin Gel |
| Baudax Bio INC. | $33.67 | 2021 | |
| Lundbeck LLC | $33.66 | 2022-2023 | Vyepti |
| Forte Bio-Pharma LLC | $28.32 | 2024 | Prolate, Nalocet |
| Biotronik Nro, INC. | $26.99 | 2025 | Prospera |
| Abbott Laboratories | $26.93 | 2022 | |
| Spinal Simplicity, LLC | $24.27 | 2025 | Ha Minuteman G3-R |
| Lilly USA, LLC | $22.01 | 2023 | Emgality, Reyvow |
| Arbor Pharmaceuticals, INC. | $19.73 | 2022 | |
| Scilex Pharmaceuticals INC. | $18.20 | 2022 | |
| Relievant Medsystems, INC. | $18.18 | 2023 | Intracept |
| Acelrx Pharmaceuticals, INC. | $17.91 | 2021 | |
| Avanos Medical | $17.46 | 2024 | Standard Rf Disposables |
| Pacira Pharmaceuticals Incorporated | $16.47 | 2023 | Exparel, Zilretta, Iovera |
| Trevena, INC. | $15.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Linville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.